Skip to content

Middle Age muScle Krill Study

The Effect of Krill Oil Supplementation on Muscle Function and Mass in Middle-aged Adults: A Randomised Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06005064
Acronym
MASK
Enrollment
92
Registered
2023-08-22
Start date
2023-11-01
Completion date
2025-10-31
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Keywords

Krill oil, Muscle strength, Muscle mass, Middle-aged

Brief summary

This study will determine the effect of 6 months of supplementation with krill oil on muscle strength and mass in middle-aged adults. The study hypothesis is that krill oil supplementation will increase muscle strength and mass in middle-aged adults.

Interventions

DIETARY_SUPPLEMENTKrill oil

Superba krill oil

DIETARY_SUPPLEMENTVegetable oil

Mixed vegetable oil

Sponsors

University of Glasgow
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Supplements will be identical in look and taste

Intervention model description

1:1 basis

Eligibility

Sex/Gender
ALL
Age
35 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Be 35-60 years old * Have a BMI of less than 35kg/m2

Exclusion criteria

* People with diabetes, severe cardiovascular disease, seizure disorders, uncontrolled hypertension (\>150/90mmHg at baseline measurement), cancer or cancer that has been in remission \<5 years, ambulatory impairments which would limit the ability to perform assessments of muscle function, dementia, on anticoagulant therapy, and/or taking medication known to affect muscle (e.g., steroids). * People who have allergies to seafood, and/or regular consumption of more than 1 portion of oily fish per week. * People who perform regular (\>1 day/week) resistance exercise training.

Design outcomes

Primary

MeasureTime frameDescription
Change in knee extensor maximal isometric torque ( MVC)Change from baseline to 24 weeksKnee extensor maximal isometric torque measured during a maximal voluntary contraction

Secondary

MeasureTime frameDescription
Change in lean massChange from baseline to 24 weeksWhole body lean mass measured by measured via bio-electrical impedance
Change in omega-3 levelsChange from baseline to 24 weeksRed blood cell omega-3 levels
Change in Grip strengthChange from baseline to 24 weeksGrip strength measured with a hand held dynamometer
Change in Muscle thicknessChange from baseline to 24 weeksVastus lateralis muscle thickness measured by ultrasound
Change in fat massChange from baseline to 24 weeksWhole body fat mass measured by measured via bio-electrical impedance

Other

MeasureTime frameDescription
Change in muscle anabolic signallingChange from baseline to 24 weeksMuscle total and phosphorylated protein levels of mTOR, IRS-1, Akt, 4EBP-1, p70S6K, RPS6, FOXO-1, GSK3β and total protein levels of MAFBx and MURF-1
Change in muscle inflammationChange from baseline to 24 weeksMuscle total protein levels of TNF-α, IL-1β, IL-6, IL-8, MCP-1 and total and phosphorylated levels of NFκB, JNK1/2 and STAT3
Change in systemic inflammationChange from baseline to 24 weeksPlasma levels of C-reactive protein, IL-1, IL-6, IL-8, IL-10, and TNF-α

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026